1. Knowing the differential diagnosis of ambiguous genitalia in the neonate will lead to more appropriate diagnostic evaluation and timely management.
INTRODUCTION
Infants whose genitalia cannot clearly be classified as either a male or female phenotype are considered to have a disorder of sexual development (DSD). Evaluating a newborn with ambiguous genitalia can be challenging and requires prompt investigation to determine the underlying cause. A multidisciplinary team approach including neonatology, endocrinology, gynecology, urology, genetics, ethics, social work, and psychology is recommended when evaluating infants with ambiguous genitalia. Parents should always be included in discussions about evaluation and management, and they should be key stakeholders in the sex-assignment decision.
DSD can be classified into 3 broad categories: 46,XX DSD, 46,XY DSD, and sex chromosome DSD. A systematic approach in the evaluation of ambiguous genitalia can help discover the underlying etiology in many cases, but an etiology may not be identified. This article focuses on the process of normal sexual development and describes the clinical evaluation and treatment of newborns with ambiguous genitalia.
NORMAL SEXUAL DIFFERENTIATION
During early embryogenesis, the gonads and internal structures of male and female fetuses are phenotypically identical and bipotential. The bipotential gonad differentiates into either an ovary or a testis, depending on specific gene expression. The first step in male sex development is expression of the sex-determining region on the Y chromosome (SRY), which occurs around the sixth week of gestation. SRY triggers further sex-determining genes and transcription factors that are necessary for maturation and differentiation of cell types in the testis, including Sertoli and Leydig cells. Around the eighth week of gestation, the primitive testes begin to produce hormones. Production of testosterone by the Leydig cells leads to development of the wolffian ducts into male internal genitalia (epididymis, vas deferens, and seminiferous tubules). Production of anti-müllerian hormone (AMH) by the Sertoli cells leads to involution of the müllerian (female) internal ducts. The development of the external male genitalia is dependent on the activity of dihydrotestosterone (DHT), which is converted from testosterone by the enzyme 5a-reductase. DHT induces development of the penis from the genital tubercle, development of the urethra from the urogenital sinus, and fusion of the labioscrotal folds to form the scrotum.
In the absence of SRY, the gonadal cells in the XX embryo develop into ovarian granulosa and theca cells. The absence of AMH allows the müllerian ducts to develop into the internal female genitalia (uterus, fallopian tubes, and upper one-third of the vagina), and the wolffian ducts regress. Without testosterone and DHT, the genital tubercle will form the clitoris, the urethral folds become the labia minora, and the labioscrotal swellings become the labia majora, leading to a female external phenotype.
46,XX DSD
46,XX DSDs can be subdivided into either disorders of androgen excess or disorders of ovarian development. These conditions are summarized in Table 1 .
The most common cause of genital ambiguity in a 46,XX female is congenital adrenal hyperplasia (CAH). CAH is an autosomal recessive condition with a defect in the synthesis of cortisol. The most common cause of CAH is 21-hydroxylase deficiency, which accounts for 95% of cases; however, 11-hydroxylase deficiency and 3b-hydroxysteroid dehydrogenase (HSD) deficiency can also cause virilization of a female infant. The block in the production of cortisol leads to shunting of cortisol precursors toward the androgen pathway, which leads to virilization of the external genitalia. 46,XX individuals with CAH have normal female internal genital development. Females born with CAH can present with a wide range of genital ambiguity, from mild clitoromegaly to phenotypicappearing males with empty scrotal sacs. Figure 1 shows a severely virilized female infant with 21-hydroxylase deficiency. Infants with classic 21-hydroxylase deficiency also have deficient aldosterone production and can present with a saltwasting crisis (hyponatremia, hyperkalemia, hypoglycemia, hypovolemia, shock). All states now have newborn screening programs that measure 17-hydroxyprogesterone levels, which are elevated in cases of 21-hydroxylase deficiency.
Aromatase deficiency is a condition in which patients are unable to convert androgen precursors to estrogen. Aromatase deficiency in the placenta leads to virilization of both the mother and the fetus. Maternal causes of androgen excess that can lead to virilization of a 46,XX infant include ingestion of androgens or progestins, virilizing adrenocortical tumors, ovarian tumors, or luteomas.
Disorders of ovarian development in a 46,XX individual that can present with ambiguous genitalia include ovotesticular DSD and 46,XX testicular DSD. In ovotesticular DSD, the gonad contains both ovarian and testicular tissue. Patients with ovotesticular DSD can present with a spectrum of genital ambiguity as well as both male and female internal duct structures. In 46,XX testicular DSD, both ofhypospadias and undescended testes, though in many cases they are phenotypically normal males who present later in life because of infertility.
46,XY DSD
46,XY DSDs can be classified further into disorders of testicular development and disorders of androgen synthesis or action. These conditions are summarized in Table 2 .
Disorders of testicular development include gonadal dysgenesis, gonadal regression or vanishing testes syndrome, and XY ovotesticular DSD. In 46,XY complete gonadal dysgenesis (Swyer syndrome), no testicular development occurs and patients appear as phenotypic females with bilateral streak gonads and normal müllerian structures. Patients with 46,XY partial gonadal dysgenesis have some degree of testicular development and can present with variable internal and external phenotypes depending on how functional the testes are. Several syndromes, including camptomelic dysplasia, Frasier syndrome, and Denys-Drash syndrome, are associated with XY gonadal dysgenesis. Vanishing testes or testicular regression syndrome is a condition in which testes are absent in a 46,XY individual. These individuals are thought to have disappearance or regression of the testes in utero after an insult such as torsion or vascular thrombosis. The appearance of the external genitalia depends on the timing of the testicular regression in relation to sexual development: testicular regression before 8 weeks of gestation results in a phenotypic female, loss between 8 and 10 weeks results in ambiguous genitalia, and loss after 12 weeks will result in normal male external genitalia.
XY ovotesticular DSD is a condition in which an XY individual has both ovarian and testicular tissue. Patients with XY ovotesticular DSD most commonly present with ambiguous genitalia or severe hypospadias.
Disorders of androgen action include complete or partial androgen insensitivity. These conditions result from mutations in the androgen receptor gene. The phenotype of patients with androgen insensitivity depends on the degree of tissue responsiveness to androgen activity. Patients with complete androgen insensitivity have female external genitalia with a blind vaginal pouch. These individuals typically present in adolescence with primary amenorrhea, though in some instances they are identified earlier because of inguinal or labial swellings containing testes. Patients with partial androgen insensitivity can present with a wide range of phenotypes, from ambiguous genitalia to phenotypic males who present with infertility in adulthood.
Disorders of androgen synthesis include testosterone biosynthesis enzyme defects, Leydig cell aplasia or hypoplasia, and 5a-reductase deficiency. Enzymatic defects in the adrenal gland or testes can lead to decreased production of testosterone and cause undervirilization in 46,XY individuals. The adrenal biosynthesis pathway is shown in Fig 2. As shown in the figure, the synthesis of testosterone begins e148 NeoReviews by guest on September 20, 2017 http://neoreviews.aappublications.org/ Downloaded from ranging from micropenis, perineal hypospadias, and cryptorchidism to a complete female external phenotype. 17b-HSD type III deficiency leads to an inability to convert androstenedione to testosterone. These XY individuals can have either a female or ambiguous external phenotype.
Mutations in the luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor can lead to testicular Leydig cell aplasia or hypoplasia. Without normal production of testosterone by the Leydig cells, undervirilization of the XY male will occur. The extent of undervirilization depends on the degree of Leydig cell hypoplasia.
5a-reductase deficiency leads to a defect in the conversion of testosterone to DHT. Without adequate levels of DHT to virilize the external genitalia, XY individuals can present with ambiguous genitalia, micropenis, hypospadias, or female external genitalia. These patients can have spontaneous virilization during puberty because of the increased testosterone levels. 
SEX CHROMOSOME DSD

DIAGNOSTIC EVALUATION
Clinical features that raise suspicion of a DSD include apparent female genitalia with clitoromegaly, inguinal or labial mass, or posterior labial fusion; micropenis with bilateral nonpalpable testes, hypospadias with undescended testes, isolated penoscrotal, or perineoscrotal hypospadias; or a discordance between prenatal karyotype and genital appearance. Clitoromegaly is defined as a clitoral length greater than 9 mm or clitoral width greater than 6 mm in a full-term infant. A stretched penile length that is -2.5 SD below the mean for age is considered to be a micropenis.
The evaluation of a newborn with ambiguous genitalia requires a thorough history, physical examination, laboratory testing, and imaging studies. Parents should be asked about consanguinity, which may indicate an increased risk of autosomal recessive disorders, such as CAH. A history of unexplained infant deaths in the family can also be concerning for undiagnosed salt-wasting CAH. A family history of ambiguous genitalia, urologic anomalies, or female infertility/amenorrhea should also be obtained. Mothers should be asked about the use of any drugs or exposure to environmental factors that could lead to virilization of a female infant. Maternal virilization should be noted because it could suggest a maternal tumor that produced excess androgen. Results of any prenatal tests, including ultrasonography and karyotyping, should be obtained.
The physical examination should begin with a general assessment. As mentioned previously, some syndromes are associated with genital ambiguity and have characteristic physical features. Any dysmorphic features or malformations should be noted because they may suggest an underlying genetic disorder. Midline defects can be associated with hypothalamic-pituitary abnormalities and can cause hypogonadotropic hypogonadism. Hypertension and dehydration can be associated with some forms of CAH, so it is important to evaluate hydration status and blood pressure. Jaundice may be a sign of cortisol deficiency or hypopituitarism. The examination of the external genitalia should include the development of the genital tubercle, which forms the penis in males and the clitoris in females. The degree of fusion of the labioscrotal folds should be noted, as should the texture and pigmentation of the genital skin. It is important to palpate the labioscrotal folds and inguinal regions bilaterally for the presence of gonads. A palpable external gonad will be either a testes or an ovotestes. The size and location of the gonads should be documented. A stretched phallic length and width should be measured, and the presence or absence of chordee should be noted. The location of the urethral opening or urogenital sinus should be determined (are there separate vaginal and urethral openings, or is there a common channel?). The degree of hypospadias should be documented if present (is the urethral opening proximal/perineal, mid-shaft, or distal/ glandular on the ventral surface of the phallic structure?). In contrast to hypospadias, epispadias is the opening of the urethral or urogenital sinus on the dorsal surface of the phallic structure. Epispadias is a rare occurrence and can be part of a spectrum of conditions in which there is failure of fusion of abdominal or pelvic organs, including the external genitalia.
All patients with ambiguous genitalia or a question of sex assignment require a routine chromosome analysis as initial investigation. It should be obtained within the first 24 hours after birth, and the laboratory should be notified to expedite the results. A chromosomal microarray analysis is recommended to look for small deletions or duplications that may not be identified on routine karyotype. For patients with ambiguous genitalia and nonpalpable gonads, there should be a high suspicion of CAH. Initial evaluation should include measurement of serum electrolytes to look for salt wasting, serum glucose that may be low in cases of cortisol deficiency, and 17-hydroxyprogesterone to evaluate for 21-hydroxylase deficiency. A corticotropin (ACTH)-stimulation test may be necessary to evaluate the cortisol response and enzymatic deficiencies that can cause CAH. It can be done by obtaining baseline and ACTH-stimulated levels of cortisol, 17-hydroxyprogesterone, 17-hydroxypregnenolone, progesterone, androstenedione, dehydroepiandrosterone, deoxycorticosterone, 11-deoxycortisol, and testosterone. The ACTH-stimulation test should not delay treatment in cases of suspected CAH. In any suspected case of CAH, renin and aldosterone levels also should be obtained.
Additional testing includes baseline gonadotropins (LH and follicle-stimulating hormone), which may be low in cases of hypogonadotropic hypogonadism and indicative of possible pituitary deficiency. Hypogonadotropic hypogonadism can be a cause of micropenis in 46,XY individuals. An AMH level is a reliable marker of the presence and function of testicular tissue and can be helpful in evaluating undervirilized XY individuals. AMH levels will be low in cases of vanishing testes, XY gonadal dysgenesis, or persistent mül-lerian duct syndrome. AMH levels can be elevated in cases of androgen insensitivity and hypogonadotropic hypogonadism. An hCG-stimulation test is used to evaluate the production of testosterone from testicular tissue. The hCG-stimulation test requires measuring baseline and stimulated levels of testosterone and DHT. The ratio of testosterone to DHT will be elevated in cases of 5a-reductase deficiency. An inadequate response to hCG stimulation in an XY individual can be indicative of gonadal dysgenesis, ovotesticular DSD, LH receptor defect, or hypogonadotropic hypogonadism. High testosterone levels in an undervirilized 46,XY patient should raise suspicion for androgen insensitivity, and genetic testing should be considered.
The internal anatomy of any patient with ambiguous genitalia should be evaluated with pelvic/abdominal ultrasonography or magnetic resonance imaging. Imaging can identify the presence or absence of müllerian structures (uterus) and the location of gonadal tissue. Gonadal biopsy may be necessary to determine the type of gonadal tissue in cases of suspected ovotesticular DSD or gonadal dysgenesis.
MANAGEMENT
The uncertainty of an infant's gender is stressful and upsetting to families. The prompt involvement of a multidisciplinary team that is knowledgeable in DSD is essential when evaluating these patients. This team should include endocrinology, urology, gynecology, genetics, psychology, social work, and ethics. Ruling out life-threatening emergencies such as CAH should be the initial priority. The parents should be involved in all discussions regarding sex assignment and should be updated on testing results as they become available. Although parents are eager to tell friends and family the sex of their newborn, it is important that careful consideration and thorough evaluation are complete before a sex assignment decision is made. Before making the final sex assignment, it is important to use genderneutral terms when discussing the infant such as "baby" instead of using "she" or "he." It is recommended that parents meet with a psychologist who can help them with coping techniques and provide guidance on how to talk to friends and family about their newborn. Many factors, including phenotypic sex (appearance of the external and internal genitalia), genotypic sex (karyotype), hormonal sex (hormonal profile: testosterone, DHT, adrenal steroid profile), reproductive sex (potential to have biological children), and parental perception, influence sex assignment. Discussing each of these components of sexual development with the family can help demystify the process and reduce anxiety for families as they participate in the sex assignment process.
Surgical intervention (gonadoplasty, vaginoplasty, gonadectomy) must be delayed until a clear diagnosis is established and should be performed only by an experienced surgeon. The benefits of any surgical or medical procedure must clearly outweigh the risks, and any unnecessary procedures should be delayed until the child is old enough to make an informed decision.
Once a sex-assignment decision is made, the child and family will need long-term follow-up with medical providers who are experienced with DSD. Ongoing education is essential, because many of these patients will require surgery and hormonal therapy. It is important to assess the patient's and parents' satisfaction with the sex-assignment decision. Psychological assessment at regular intervals is recommended to screen for mental health issues such as gender dysphoria and to provide support for families.
CONCLUSIONS
The finding of ambiguous genitalia in the newborn can be distressing to both health-care providers and families. A thorough, stepwise approach to diagnosis that involves a multidisciplinary team is necessary. Each case of ambiguous genitalia is unique, and a basic understanding of the differential diagnosis of DSD can help guide the evaluation of these newborns. Open communication between the medical team and the families is important, and the families must be involved in all decisions about sex assignment and surgical management. American Board of Pediatrics Neonatal-Perinatal Content Specifications
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• Know normal fetal sexual differentiation.
• Differentiate among disorders of testicular hormone synthesis or action.
• Know the etiology of abnormal sexual differentiation.
• Know the diagnostic approaches to and management of abnormal sexual differentiation.
• Know the etiology of and diagnostic approaches to an infant with ambiguous genitalia, not including congenital adrenal hyperplasia.
• Know how to evaluate and manage an infant with micropenis.
• Know how to evaluate and manage an infant with hypospadias and epispadias.
are seen, usually in consanguineous families. Mutations of transcription factors HESX1, SOX2, and SOX3 have been reported in patients with SOD. (5)
Management
The mainstay of treatment is replacement with appropriate hormones. Neonates diagnosed with congenital hypopituitarism require monitoring for evolving hormone deficiencies. Life-long follow-up by a multidisciplinary team aims to address the complex needs of those patients, including periodic visual and auditory assessments and neurodevelopmental support. Genetic counseling should be offered in cases in which a genetic defect has been detected.
Clinical Course of the Index Newborn
The infant started receiving thyroid hormone supplementation and stress dose steroids, leading to normalization of his glucose levels and symptom resolution. He also started receiving human growth hormone supplementation, and received a dose of testosterone in hopes of phallus size normalization. He was diagnosed with bilateral mild highfrequency sensorineural hearing loss, but has been meeting developmental milestones up to this point.
Lessons for the Clinician
• Persistent, clinically symptomatic hypoglycemia can be a sign of a serious endocrine disorder requiring specific treatment beyond maintenance intravenous glucose.
• Use of critical hypoglycemia laboratory values for neonates, paired with careful evaluation of clinical findings, including penile size and dysmorphic features, allow for timely identification of the source of hypoglycemia and narrowing of the differential diagnosis.
• Brain magnetic resonance imaging is an important diagnostic tool in neonates with hypopituitarism, allowing identification of structural brain anomalies suggestive of septo-optic dysplasia.
